Table 1.

Cohort demographic and clinical characteristics

CharacteristicValue
Number of patients1316
Female582 (44.2)
Age at start of PD (yr)67.5 (11.8)a
Age at death (yr)70.4 (11.7)a
Time on PD (yr)2.3 (1.4–3.9)b
State of residence
 New South Wales and Australian Capital Territory556 (42.2)
 Victoria234 (17.8)
 Western Australia125 (9.5)
 Queensland271 (20.6)
 Tasmania21 (1.6)
 South Australia88 (6.7)
 Northern Territory21 (1.6)
Region of residence
 major city720 (54.7)
 regional345 (26.2)
 remote69 (5.3)
 unknown182 (13.8)
Ethnicity
 Caucasian1023 (77.8)
 Asian141 (10.7)
 Pacific34 (2.6)
 Aboriginal and Torres Strait Islander117 (8.9)
Cause of death
 peritonitis78 (5.9)
 other infection115 (8.7)
 cardiac578 (43.9)
 cerebrovascular107 (8.1)
 peripheral vascular48 (3.6)
 malignancy96 (7.3)
 withdrawal174 (13.2)
 other120 (9.1)
Number of peritonitis episodes
 0584 (44.4)
 1380 (28.9)
 2170 (12.9)
 ≥3182 (13.8)
Median days from peritonitis to death247 (64–552)b
Smoking status
 current145 (11.0)
 former581 (44.1)
 never590 (44.8)
Body mass index (kg/m2)
 <20106 (8.1)
 20.0–24.9456 (34.9)
 25.0–29.9472 (36.1)
 ≥30273 (20.9)
Diabetes53 (4.0)
 type I330 (25.1)
 type II noninsulin requiring312 (23.7)
 type II insulin requiring
Other comorbidities
 chronic lung disease369 (28.0)
 coronary artery disease1029 (78.2)
 peripheral vascular disease710 (54.4)
 cerebrovascular disease508 (38.6)
 no comorbidity78 (5.9)
Membrane transport status
 low52 (4.0)
 low average327 (24.8)
 high average479 (36.4)
 high191 (14.5)
 unknown267 (20.3)
Kt/V (total)1.8 (0.6)a
  • Data are presented as n (%) unless otherwise noted.

  • a Mean (SD)

  • b 25th and 75th percentile.